Lombard Odier Asset Management (USA)’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,056
Closed -$720K 334
2024
Q3
$535K Buy
+29,056
New +$520K 0.04% 198
2023
Q4
Sell
-15,957
Closed -$100K 388
2023
Q3
$100K Buy
+15,957
New +$119K ﹤0.01% 327
2023
Q2
Sell
-12,374
Closed -$123K 393
2023
Q1
$123K Buy
+12,374
New +$108K ﹤0.01% 292
2022
Q4
Sell
-25,862
Closed -$144K 357
2022
Q3
$144K Sell
25,862
-13,048
-34% -$78.6K ﹤0.01% 325
2022
Q2
$176K Buy
38,910
+17,905
+85% +$76.4K 0.01% 291
2022
Q1
$112K Sell
21,005
-40,723
-66% -$201K ﹤0.01% 276
2021
Q4
$404K Buy
+61,728
New +$446K 0.02% 255

Other funds holding HIMS

Lombard Odier Asset Management (USA)'s HIMS Position: Q4 2024 in Review

Lombard Odier Asset Management (USA) sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 29,056 shares — an estimated $720K sold.

Lombard Odier Asset Management (USA) first reported a position in HIMS in Q4 2021 and held it in 7 quarters. The position peaked at $535K in Q3 2024. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Lombard Odier Asset Management (USA) reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 29,056 Hims & Hers Health shares in Q4 2024, an estimated $720K.
  • Lombard Odier Asset Management (USA) first reported a position in Hims & Hers Health in Q4 2021 and held it in 7 quarters.
  • Lombard Odier Asset Management (USA)'s Hims & Hers Health position peaked at $535K in Q3 2024.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2024, filed 14 Feb 2025.